Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Payables (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Payables for 16 consecutive years, with $6.9 million as the latest value for Q3 2025.

  • Quarterly Payables fell 17.38% to $6.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.9 million through Sep 2025, down 17.38% year-over-year, with the annual reading at $7.9 million for FY2024, 12.25% up from the prior year.
  • Payables for Q3 2025 was $6.9 million at Xtant Medical Holdings, down from $7.2 million in the prior quarter.
  • The five-year high for Payables was $8.3 million in Q3 2024, with the low at $2.4 million in Q3 2021.
  • Average Payables over 5 years is $5.0 million, with a median of $4.4 million recorded in 2023.
  • The sharpest move saw Payables plummeted 31.01% in 2021, then skyrocketed 115.67% in 2024.
  • Over 5 years, Payables stood at $2.6 million in 2021, then soared by 33.46% to $3.5 million in 2022, then surged by 102.12% to $7.1 million in 2023, then grew by 12.25% to $7.9 million in 2024, then decreased by 13.41% to $6.9 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $6.9 million, $7.2 million, and $7.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.